Khaldon Bodoor - Publications

Affiliations: 
2011-2014 Pharmacology Duke University, Durham, NC 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Merlos Rodrigo MA, Jimenez Jimemez AM, Haddad Y, Bodoor K, Adam P, Krizkova S, Heger Z, Adam V. Metallothionein isoforms as double agents - Their roles in carcinogenesis, cancer progression and chemoresistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 52: 100691. PMID 32615524 DOI: 10.1016/J.Drup.2020.100691  0.375
2020 Bodoor K, Almomani R, Alqudah M, Haddad Y, Samouri W. LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target. Asian Pacific Journal of Cancer Prevention : Apjcp. 21: 1453-1458. PMID 32458655 DOI: 10.31557/Apjcp.2020.21.5.1453  0.315
2020 Kaneko K, Osada T, Morse MA, Gwin WR, Ginzel JD, Snyder JC, Yang XY, Liu CX, Diniz MA, Bodoor K, Hughes PF, Haystead TA, Lyerly HK. Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Communications Biology. 3: 226. PMID 32385408 DOI: 10.1038/s42003-020-0956-7  0.624
2018 Bodoor K, Abu-sheikha A, Matalka I, Alzou’bi H, Batiha O, Abu-Awad A, Jalboush SA, Fayyad LM, Qadiri E, Jarun Y, Albatayneh K, Haddad Y. Immunohistochemical analysis of heat shock proteins in triple negative breast cancer: HSP60 expression is a marker of poor prognosis European Journal of Gynaecological Oncology. 39: 926-934. DOI: 10.12892/Ejgo4347.2018  0.395
2017 Totzke J, Gurbani D, Raphemot R, Hughes PF, Bodoor K, Carlson DA, Loiselle DR, Bera AK, Eibschutz LS, Perkins MM, Eubanks AL, Campbell PL, Fox DA, Westover KD, Haystead TAJ, et al. Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease. Cell Chemical Biology. 24: 1029-1039.e7. PMID 28820959 DOI: 10.1016/J.Chembiol.2017.07.011  0.641
2016 Bodoor K, Jalboush SA, Matalka I, Abu-Sheikha A, Waq RA, Ebwaini H, Abu-Awad A, Fayyad L, Al-Arjat J, Haddad Y. Heat Shock Protein Association with Clinico-Pathological Characteristics of Gastric Cancer in Jordan : HSP70 is Predictive of Poor Prognosis. Asian Pacific Journal of Cancer Prevention : Apjcp. 17: 3929-37. PMID 27644641  0.315
2015 Lontay B, Bodoor K, Sipos A, Weitzel DH, Loiselle D, Safi R, Zheng D, Devente J, Hickner RC, McDonnell DP, Ribar T, Haystead TA. Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice. The Journal of Biological Chemistry. 290: 17985-98. PMID 26048986 DOI: 10.1074/Jbc.M115.658120  0.556
2014 Howe MK, Bodoor K, Carlson DA, Hughes PF, Alwarawrah Y, Loiselle DR, Jaeger AM, Darr DB, Jordan JL, Hunter LM, Molzberger ET, Gobillot TA, Thiele DJ, Brodsky JL, Spector NL, et al. Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. Chemistry & Biology. 21: 1648-59. PMID 25500222 DOI: 10.1016/J.Chembiol.2014.10.016  0.689
2012 Hughes PF, Barrott JJ, Carlson DA, Loiselle DR, Speer BL, Bodoor K, Rund LA, Haystead TA. A highly selective Hsp90 affinity chromatography resin with a cleavable linker. Bioorganic & Medicinal Chemistry. 20: 3298-305. PMID 22520629 DOI: 10.1016/J.Bmc.2012.03.043  0.631
2011 Bodoor K, Lontay B, Safi R, Weitzel DH, Loiselle D, Wei Z, Lengyel S, McDonnell DP, Haystead TA. Smoothelin-like 1 protein is a bifunctional regulator of the progesterone receptor during pregnancy. The Journal of Biological Chemistry. 286: 31839-51. PMID 21771785 DOI: 10.1074/Jbc.M111.270397  0.583
2010 Lontay B, Bodoor K, Weitzel DH, Loiselle D, Fortner C, Lengyel S, Zheng D, Devente J, Hickner R, Haystead TA. Smoothelin-like 1 protein regulates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy. The Journal of Biological Chemistry. 285: 29357-66. PMID 20634291 DOI: 10.1074/Jbc.M110.143966  0.569
2010 Bodoor K, Ghabkari A, Jaradat Z, AlKhateeb A, Jaradat S, Al-Ghazo MA, Matalka I, Musleh H, Haddad Y. FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population Cancer Epidemiology. 34: 724-732. PMID 20542753 DOI: 10.1016/J.Canep.2010.05.003  0.302
Show low-probability matches.